Dr. Reddy’s launches anti acne drug Nexret
Hyderabad, India, April 28, 2009 – Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) has launched Nexret (Tretinoin 0.04% & 0.1% as microspheres) in India. It marks the entry of Dr. Reddy’s into the topical anti-acne segment, a commonly diagnosed condition by dermatologist.
Nexret is a next generation anti-acne formulation made from a proprietary non-porous microsphere technology. This unique technology minimizes irritation associated with drugs like Tretinoin and provides controlled delivery of drug to the skin.
Nexret is available in gel formulation and in pack size of 15 gms.
The anti-acne market in India is about Rs 130 crores growing at the rate of about 14%.(Source: ORG IMS)
If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.
Comments
No comments yet.
Leave a comment